Efficacy of Topical Beta‐Blockers in Managing Epidermal Growth Factor Receptor Inhibitor‐Related Paronychia and Pyogenic Granuloma‐Like Lesion: A Systematic Review and Meta‐Analysis

Our research concluded that topical beta-blockers may be a well-tolerated and beneficial option for managing EGFR inhibitor-induced paronychia and PGL. Additional and large-scale randomized controlled trials are necessary to confirm these findings, standardize treatment protocols, and evaluate long-term effectiveness.